Vincent Wong

Vince Wong brings significant valuable multinational and startup company experience to BioCrossroads and the Indiana Seed Funds where he joined as CEO in 2024. With Vince’s leadership, BioCrossroads brings together industry, academia, government, and philanthropy to advance Indiana’s life science sector, the nation’s leading exporter of life science products. BioCrossroads and its seed funds enable and fund startups, expand
manufacturing, advance workforce development, and drive attraction and retention of life science companies, talent, and capital for Indiana.

Prior to BioCrossroads, Vince served as chief commercial o cer at Geneoscopy, a
venture-backed startup focused on developing RNA-based gastrointestinal diagnostics. His responsibilities included business development, government affairs, market access,sales, marketing, and communications. He also helped raise over $100M for the company's series B round and helped secure the lead investor in its $100M series C round.

Prior to Geneoscopy, Vince enjoyed an 18-year career at Roche Diagnostics, where he held
senior leadership roles, including leading the $600M Specialty Diagnostics business unit
with over 400 team members.

Vince serves as a director on the board of Bionano Genomics (Nasdaq: BNGO) and Executive in Residence with IU Ventures.
Vince is an active community leader and has served on the boards of numerous civic and
arts organizations, including the Indy Chamber, Dance Kaleidoscope, Asian American Alliance, International Violin Competition of Indianapolis, and the Indianapolis Museum of Art. Vince serves on the boards of the Indiana Biosciences Research Institute and OrthoWorx and board of advisors for Indiana University Indianapolis. Vince was recognized
among both the 40 Under Forty and Indiana 250 by the Indianapolis Business Journal.
Vince earned a BA from the University of Notre Dame, a JD from Indiana University's
Maurer School of Law, and an MBA from Northwestern’s Kellogg School of Management.